Viiv Healthcare, The Global Specialist Hiv Company Majority-Owned By Gsk With Pfizer And Shionogi As Shareholders, Announced It Obtained Approval For Vocabria (Cabotegravir Injection And Tablets) Used In Combination With Janssen Pharmaceutical Companies Of Johnson & Johnson
